Decreased quality of life and spirometric alterations even after mild-moderate COVID-19

被引:19
|
作者
Navarro, Alberto Ordinola [1 ]
Cervantes-Bojalil, Javier [1 ]
Cobos Quevedo, Orestes de Jesus [1 ]
Avila Martinez, Andrea [1 ]
Alberto Hernandez-Jimenez, Carlos [1 ]
Perez Alvarez, Esperanza [1 ]
Gonzalez Gil, Andrea [1 ]
Peralta Amaro, Ana Lilia [1 ]
Vera-Lastra, Olga [1 ]
Lopez Luis, Bruno Ali [2 ]
机构
[1] Hosp Especialidades Dr Antonio Fraga Mouret, Ctr Med Nacl La Raza Inst Mexicano Seguro Social, Dept Internal Med, Mexico City, DF, Mexico
[2] Hosp Gen Zona 27, Dept Internal Med, Inst Mexicano Seguro Social, Mexico City, DF, Mexico
关键词
COVID-19; Pulmonary Rehabilitation; Post-COVID; Quality of life; Respiratory infection; SARS;
D O I
10.1016/j.rmed.2021.106391
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The follow-up of recovered COVID-19 patients is still limited. We aimed to evaluate the changes in quality-of-life (QOL) and spirometric alterations in the convalescent phase of 115 patients with at least 30 days post-COVID-19. Methods: We included patients with confirmed COVID-19 infection, available past medical records and at least 30 days after the onset of symptoms. All patients were asked to rate their general health condition before and after COVID-19 using the EQ-5D-5L standardized questionary and perform a spirometry at evaluation. Results: In this study, that included 70%(81/115) of patients with mild or moderate COVID-19; there was a severe decrease in QOL up to 56%(64/115). Alterations in usual activities and anxiety/depression were present in 59% of patients with a severe decrease in QOL. The persistence of symptoms was present in 63%(72/115). Restrictive lung impairment was the most common spirometric alteration in 17%(20/115), of whom 65%(13/20) had mild COVID-19. Conclusions: Spirometric alterations are presented even in mild COVID-19, and more remarkably, there is a high rate of alterations in quality of life after the recovery of this disease.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild-moderate COVID-19 and prevention of post-COVID cognitive impairment
    Gomaa, Adel A.
    Abdel-Wadood, Yasmin A.
    Gomaa, Mohamed A.
    INFLAMMOPHARMACOLOGY, 2022, 30 (06) : 1977 - 1992
  • [22] Neurological manifestations in mild and moderate cases of COVID-19
    Ghada Saed Abdel Azim
    Marwa Abdellah Osman
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57
  • [23] Neurological manifestations in mild and moderate cases of COVID-19
    Azim, Ghada Saed Abdel
    Osman, Marwa Abdellah
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2021, 57 (01)
  • [24] COVID-19 and Quality of Life: Twelve Reflections
    Shek, Daniel T. L.
    APPLIED RESEARCH IN QUALITY OF LIFE, 2021, 16 (01) : 1 - 11
  • [25] COVID-19 and Quality of Life: Twelve Reflections
    Daniel T. L. Shek
    Applied Research in Quality of Life, 2021, 16 : 1 - 11
  • [26] Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study
    Anouk Verveen
    Elke Wynberg
    Hugo D. G. van Willigen
    Udi Davidovich
    Anja Lok
    Eric P. Moll van Charante
    Menno D. de Jong
    Godelieve de Bree
    Maria Prins
    Hans Knoop
    Pythia T. Nieuwkerk
    BMC Medicine, 20
  • [27] Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study
    Verveen, Anouk
    Wynberg, Elke
    van Willigen, Hugo D. G.
    Davidovich, Udi
    Lok, Anja
    van Charante, Eric P. Moll
    de Jong, Menno D.
    de Bree, Godelieve
    Prins, Maria
    Knoop, Hans
    Nieuwkerk, Pythia T.
    BMC MEDICINE, 2022, 20 (01)
  • [28] Quality of life under the COVID-19 quarantine
    Lara N. Ferreira
    Luís N. Pereira
    Maria da Fé Brás
    Kateryna Ilchuk
    Quality of Life Research, 2021, 30 : 1389 - 1405
  • [29] Quality of life of patients three months after COVID-19 hypoxemic pneumonitis
    Snene, Houda
    El Wadhane, Issraa
    Blibech, Hana
    Kerkeni, Safa
    Trabelsi, Meriem
    Fenina, Wafa
    Maalej, Meriem
    Jebali, Aymen
    Mehiri, Nadia
    Ben Salah, Nozha
    Louzir, Bechir
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [30] Quality of Life and Persistence of Symptoms in Outpatients after Recovery from COVID-19
    Guadalupe Gutierrez-Canales, Lizeth
    Munoz-Corona, Carolina
    Barrera-Chavez, Isaac
    Viloria-Alvarez, Carlos
    Macias, Alejandro E.
    Guani-Guerra, Eduardo
    MEDICINA-LITHUANIA, 2022, 58 (12):